SafeCode Drug Technologies

Company Overview

Snapshot

Founded in January 2010, SafeCode Drug Technologies operates with 1–10 employees. The company is currently in a Pre-Funding stage.

Business overview

SafeCode Drug Technologies develops a patent-pending voice recognition technology designed to prevent unauthorized administration of prescription medication. The core product integrates a barcode for patient identification, a drug-name identifier, and a stored voice template system, all managed by a processing unit and software application. The company operates in the Digital Healthcare and Cyber Security sectors, serving markets related to medication administration and clinical workflow, with business models targeting both B2C and B2B segments.

Company Intelligence Q&A

What is SafeCode Drug Technologies' primary focus?

SafeCode Drug Technologies focuses on developing voice recognition technology to enhance security and prevent unauthorized administration of prescription medications.

When was SafeCode Drug Technologies founded?

SafeCode Drug Technologies was founded in January 2010.

What technology does SafeCode Drug Technologies utilize?

SafeCode Drug Technologies utilizes patent-pending voice recognition technology, combined with barcode identification and software applications, to secure drug administration.

In which sectors does SafeCode Drug Technologies primarily operate?

SafeCode Drug Technologies operates within the Digital Healthcare and Cyber Security sectors, with applications in clinical workflow and identity security.

What is the status of SafeCode Drug Technologies?

SafeCode Drug Technologies is currently in a Non Active status as of December 2018.